Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease

International Journal of Hematology

Volumn 90, Issue 2, 2009, Pages 253-260

  Teshima, Takanori ^a   Nagafuji, Koji ^a   Henzan, Hideho ^b   Miyamura, Koichi ^c   Takase, Ken ^b   Hidaka, Michihiro ^d   Miyamoto, Toshihiro ^a   Takenaka, Katsuto ^a   Akashi, Koichi ^a   Harada, Mine ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Allogeneic transplantation; Chronic GVHD; Corticosteroids; Rituximab

Indexed keywords

CORTICOSTEROID; RITUXIMAB;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HUMAN; KIDNEY INJURY; LIVER INJURY; MALE; PHASE 2 CLINICAL TRIAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350570526     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0370-x     Document Type: Article

References (34)

1. SJ Lee G Vogelsang ME Flowers 2003 Chronic graft-versus-host disease Biol Blood Marrow Transplant 9 215 233 12720215 10.1053/bbmt.2003.50026 1:CAS:528:DC%2BD3sXltFaqt7s%3D (Pubitemid 40045609)
2. AH Filipovich D Weisdorf S Pavletic, et al. 2005 National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report Biol Blood Marrow Transplant 11 945 956 16338616 10.1016/j.bbmt.2005.09.004 (Pubitemid 41754712)
3. M Arora LJ Burns SM Davies, et al. 2003 Chronic graft-versus-host disease: a prospective cohort study Biol Blood Marrow Transplant 9 38 45 12533740 10.1053/bbmt.2003.50003 (Pubitemid 41123052)
4. YW Chu RE Gress 2008 Murine models of chronic graft-versus-host disease: insights and unresolved issues Biol Blood Marrow Transplant 14 365 378 18342778 10.1016/j.bbmt.2007.12.002 1:CAS:528:DC%2BD1cXkslOrsrY%3D
5. T Teshima T Wynn R Soiffer K-I Matsuoka P Martin 2008 Chronic graft-versus-host disease: how can we release Prometheus? Biol Blood Marrow Transplant 14 142 150 18162235 10.1016/j.bbmt.2007.10.023
6. K She AL Gilman S Aslanian, et al. 2007 Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease Biol Blood Marrow Transplant 13 386 397 17382246 10.1016/j.bbmt.2006.12.441 1:CAS:528:DC%2BD2sXkslWisbs%3D (Pubitemid 46421893)
7. DB Miklos HT Kim E Zorn, et al. 2004 Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors Blood 103 353 359 14512314 10.1182/blood-2003-03- 0984 1:CAS:528:DC%2BD2cXhsFGgsQ%3D%3D (Pubitemid 38035116)
8. DB Miklos HT Kim KH Miller, et al. 2005 Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission Blood 105 2973 2978 15613541 10.1182/blood-2004-09-3660 1:CAS:528:DC%2BD2MXivFGmtbY%3D (Pubitemid 40446295)
9. E Zorn DB Miklos BH Floyd, et al. 2004 Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation J Exp Med 199 1133 1142 15096539 10.1084/jem.20031560 1:CAS:528:DC%2BD2cXjtlOjtLc%3D (Pubitemid 38619909)
10. C Zhang I Todorov Z Zhang, et al. 2006 Donor CD4+T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations Blood 107 2993 3001 16352808 10.1182/blood-2005-09-3623 1:CAS:528:DC%2BD28XjtlKksLo%3D
11. V Ratanatharathorn E Carson C Reynolds, et al. 2000 Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease Ann Intern Med 133 275 279 10929168 1:CAS:528:DC%2BD3cXmtl2rtLg%3D
12. MR Canninga-van Dijk HM van der Straaten R Fijnheer CJ Sanders JG van den Tweel LF Verdonck 2004 Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease Blood 104 2603 2606 15251978 10.1182/blood-2004-05-1855 1:CAS:528:DC%2BD2cXovVegurg%3D (Pubitemid 39331867)
13. C Cutler D Miklos HT Kim, et al. 2006 Rituximab for steroid-refractory chronic graft-versus-host disease Blood 108 756 762 16551963 10.1182/blood-2006-01-0233 1:CAS:528:DC%2BD28XntFehu7w%3D (Pubitemid 44061381)
14. M Okamoto A Okano S Akamatsu, et al. 2006 Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease Leukemia 20 172 173 16239908 10.1038/sj.leu.2403996 1:STN:280:DC%2BD283hvFWltg%3D%3D
15. F Zaja A Bacigalupo F Patriarca, et al. 2007 Treatment of refractory chronic GVHD with rituximab: a GITMO study Bone Marrow Transplant 40 273 277 17549053 10.1038/sj.bmt.1705725 1:CAS:528:DC%2BD2sXnvFaqt7c%3D
16. M Mohty N Marchetti J El-Cheikh C Faucher S Furst D Blaise 2008 Rituximab as salvage therapy for refractory chronic GVHD Bone Marrow Transplant 41 909 911 18278073 10.1038/bmt.2008.12 1:CAS:528:DC%2BD1cXmtlCjtrY%3D (Pubitemid 351761695)
17. M von Bonin U Oelschlagel J Radke, et al. 2008 Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab Transplantation 86 875 879 10.1097/TP.0b013e318183f662
18. H Oh FR Loberiza Jr MJ Zhang, et al. 2005 Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations Blood 105 1408 1416 15486071 10.1182/blood-2004-06-2385 1:CAS:528:DC%2BD2MXhsVCht70%3D (Pubitemid 40223655)
19. Y Morishima Y Morishita M Tanimoto, et al. 1989 Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group Blood 74 2252 2256 2804362 1:STN:280:DyaK3c%2FivVOlsg%3D%3D
20. Y Morishima Y Kodera N Hirabayashi, et al. 1995 Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese Bone Marrow Transplant 15 235 239 7773212 1:STN:280:DyaK2M3ptFahsQ%3D%3D
21. T Sasazuki T Juji Y Morishima, et al. 1998 Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program N Engl J Med 339 1177 1185 9780337 10.1056/NEJM199810223391701 1:STN:280:DyaK1cvkt1yqsg%3D%3D (Pubitemid 28482126)
22. Y Atsuta R Suzuki K Yamamoto, et al. 2006 Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation Bone Marrow Transplant 37 289 296 16400341 10.1038/sj.bmt. 1705247 1:STN:280:DC%2BD28%2FksFajtA%3D%3D
23. HM Shulman KM Sullivan PL Weiden, et al. 1980 Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients Am J Med 69 204 217 6996481 10.1016/0002-9343(80)90380-0 1:STN:280: DyaL3c3mtlSksg%3D%3D (Pubitemid 10036817)
24. SJ Lee JP Klein AJ Barrett, et al. 2002 Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse Blood 100 406 414 12091329 10.1182/blood.V100.2.406 1:CAS:528: DC%2BD38XlsVWgtr8%3D (Pubitemid 34761100)
25. G Akpek SJ Lee ME Flowers, et al. 2003 Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study Blood 102 802 809 12714524 10.1182/blood-2002-10-3141 1:CAS:528:DC%2BD3sXlvFCmsL8%3D (Pubitemid 36917767)
26. PJ Martin BE Storer SD Rowley, et al. 2009 Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease Blood 113 5074 5082 19270260 1:CAS:528:DC%2BD1MXmslaltb0%3D
27. V Ratanatharathorn L Ayash C Reynolds, et al. 2003 Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody Biol Blood Marrow Transplant 9 505 511 12931119 10.1016/S1083-8791(03)00216-7 1:CAS:528:DC%2BD3sXnvF2gu7k%3D (Pubitemid 38351794)
28. SZ Pavletic P Martin SJ Lee, et al. 2006 Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report Biol Blood Marrow Transplant 12 252 266 16503494 10.1016/j.bbmt.2006.01.008 (Pubitemid 43273710)
29. PJ Martin D Weisdorf D Przepiorka, et al. 2006 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report Biol Blood Marrow Transplant 12 491 505 16635784 10.1016/j.bbmt.2006.03.004 (Pubitemid 43956368)
30. P McLaughlin AJ Grillo-Lopez BK Link, et al. 1998 Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J Clin Oncol 16 2825 2833 9704735 1:CAS:528:DyaK1cXlsFCgu7c%3D
31. E Parodi B Nobili S Perrotta, et al. 2006 Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment Int J Hematol 84 48 53 16867902 10.1532/IJH97.E0518 1:CAS:528:DC%2BD28XovVSisb0%3D (Pubitemid 44756776)
32. LE van der Kolk JW Baars MH Prins MH van Oers 2002 Rituximab treatment results in impaired secondary humoral immune responsiveness Blood 100 2257 2259 12200395
33. P Roll T Dorner HP Tony 2008 Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment Arthritis Rheum 58 1566 1575 18512772 10.1002/art.23473 1:CAS:528:DC%2BD1cXotVOnsbo%3D (Pubitemid 351847509)
34. S Weller MC Braun BK Tan, et al. 2004 Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire Blood 104 3647 3654 15191950 10.1182/blood-2004-01- 0346 1:CAS:528:DC%2BD2cXhtVGltbzM (Pubitemid 39564441)